CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles
Advanced Science · 2023-08 · 10 (24)
DOI: 10.1002/advs.202301766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.06.2023. Verfasst von Jae-Sang Hong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
MicroRNAs (miRNAs) in extracellular vesicles (EVs) play essential roles in cancer initiation and progression. Quantitative measurements of EV miRNAs are critical for cancer diagnosis and longitudinal monitoring. Traditional PCR‐based methods, however, require multi‐step procedures and remain as bulk analysis. Here, the authors introduce an amplification‐free and extraction‐free EV miRNA detection method using a CRISPR/Cas13a sensing system. CRISPR/Cas13a sensing components are encapsulated in liposomes and delivered them into EVs through liposome‐EV fusion. This allows for accurately quantify specific miRNA‐positive EV counts using 1 × 10 8 EVs. The authors show that miR‐21‐5p‐positive EV counts are in the range of 2%–10% in ovarian cancer EVs, which is significantly higher than the positive EV counts from the benign cells (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Systems Biology, Massachusetts General Hospital, Boston, MA, 02114, USA.
- Cancer Center, Massachusetts General Hospital, Boston, MA, 02114, USA.
- Department of Radiology, Massachusetts General Hospital, Boston, MA, 02114, USA.
ORCID-Profile: Jae-Sang Hong, Taehwang Son, Cesar M Castro, Hyungsoon Im
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Hong, J. S., Son, T., Castro, C. M., & Im, H. (2023). CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles. Advanced Science, 10(24). https://doi.org/10.1002/advs.202301766
Vancouver
Hong JS, Son T, Castro CM, Im H. CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles. Advanced Science. 2023;10(24). doi:10.1002/advs.202301766
BibTeX
@article{Hong2023,
author = {Hong, Jae-Sang and Son, Taehwang and Castro, Cesar M and Im, Hyungsoon},
title = {CRISPR/Cas13a‐Based MicroRNA Detection in Tumor‐Derived Extracellular Vesicles},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {24},
doi = {10.1002/advs.202301766}
}
EUVIMED